| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |